IPO Observation | Taiji Tiankew Launches IPO Guidance Focused on Diabetes Drug Market
Taiji Tiankew Biotechnology (Suzhou) Co., Ltd. (\"Taiji Tiankew\"), a biopharmaceutical technology company, has signed an IPO guidance agreement with China Securities Company Limited (600999) on Augus